Haohai Biotech (06826.HK): Shareholder Lou Guoliang has reduced his holdings in the company by a total of 774,700 shares.

The Zhitong Finance and Economics APP reported that Haohai Biotechnology (06826.HK) issued an announcement stating that on May 25, 2026, the company received a "Notice Letter on the Results of Share Reduction" issued by Mr. Lou Guoliang. The time period for this share reduction plan has now expired. As of May 25, 2026, Mr. Lou Guoliang has cumulatively reduced the company's shares by 774,700 shares through centralized bidding, accounting for 0.3369% of the company's total share capital of 230 million shares.